Insights

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Fresh from an in-person visit to BioData World Conference 2021, Andrew Goulter discusses the role big pharma is playing in unlocking a complex new healthcare ecosystem. His hope? That effective data sharing and democratised access will deliver advantages for healthcare professionals and patients alike… 
 

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in bioinnovation, I’ve been part of a team addressing this issue in an ambitious project with exciting potential…

PureSentry: Can real-time contamination detection transform cell therapy manufacture? 

Cambridge Consultants Harshal Shah, head of oncology innovations for global medical technology presents on how miniature active implants are key area for innovation in next-generation drug delivery.

Medtech Connect | Beyond COVID-19 - investigating and innovating for the next generation 

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

What is it really like to work at Cambridge Consultants? Here, three senior colleagues look back on their time at the company and the experience of working here.

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. I’m proud to be part of a team of colleagues dedicated to doing something about it – by creating a guide that is helping innovators switch to alternatives.